1-((1S,3R,4R,7S)-7-Hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl)pyrimidine-2,4(1H,3H)-dione, 99.49%, 100mg

(1-ethyl-1H-imidazol-5-yl)methanol, 95.0%, 10g

2-(4-Acetylphenyl)-2,2-difluoroacetic acid, 95%, 1g

5-Bromo-4-nitrothiophene-2-carbaldehyde, 95+%, 1g

4-METHYL-5-NITRO-1H-INDAZOLE, 95%, 250mg

(2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopentanoic acid, 97%, 5g

Ethyl N-Cyanoacetimidate>98.0%(GC)5g

Ethyl 4-ethylpiperidine-4-carboxylate hydrochloride, 95.0%, 250mg

4-amino-5,6-dimethyl-1,3-dihydro-2H-benzimidazol-2-one, 95.0%, 10g

Ethyl 5-ethyl-1,2,4-oxadiazole-3-carboxylate, 95.0%, 5g

CAPSO, 100 g

6,6'-Dimethoxy-2,2'-bipyridine, 98%, 250mg

methyl 2-{[(2-ethoxy-4-formylphenoxy)acetyl]amino}benzoate, 250mg